Hyderabad, 20 February 2025 – BioAsia, Asia’s premier life sciences and health tech forum, is set to host a stellar lineup of global industry leaders, policymakers, and innovators, aiming to position India as an undisputed leader in the life sciences sector. With an impressive roster of speakers and thought-provoking discussions, BioAsia 2025 is poised to act as a ‘Catalyst of Change,’ driving rapid transformation in healthcare and biotechnology.
The much-anticipated event, scheduled for 25th and 26th February 2025, will bring together a diverse array of leaders from industry, academia, government, and startups to discuss the future of healthcare, AI-driven medical advancements, and India’s growing role in the global life sciences ecosystem.
A Power-Packed Speaker Lineup
BioAsia 2025 will feature keynote addresses from prominent figures, including Telangana’s Chief Minister, Mr. A. Revanth Reddy, and Dr. Jeannette Young, Hon’ble Governor of Queensland. Other distinguished speakers include Mr. Amitabh Kant, G20 Sherpa, and Mr. Piyush Goyal, Hon’ble Minister of Industry and Supplies, Government of India. Their insights are expected to shape discussions on policy frameworks, investment opportunities, and global collaborations in healthcare and life sciences.
Adding to the event’s prestige, industry stalwarts from leading global organizations will take center stage. The list includes Robert A. Bradway, Chairman & CEO of Amgen; Prof. Patrick Tan, Executive Director of the Genome Institute of Singapore; Dr. Ken Washington, CTO of Medtronic; and Dr. Boris Stoffel, Managing Director of Miltenyi Biotec. Their participation across eight dedicated sessions will provide deep insights into the evolving landscape of healthcare innovation.
CEO Conclave: Industry Leaders to Chart the Future of Life Sciences
One of the highlights of BioAsia 2025 is the CEO Conclave, scheduled for 25th February. This high-profile session will feature leading minds from the industry, including Dr. S. Somanath, Former Chairman of ISRO; Mr. Satish Reddy, Chairman of Dr. Reddy’s Laboratories; Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech; Dr. Satyanarayana Chava, Founder and CEO of Laurus Labs; Mr. Cesar Concepcion, Chief Commercial Officer, APMA Region, Novartis; and Mr. Winselow Tucker, President and General Manager of Lilly India.
The conclave will focus on key opportunities and challenges in the life sciences sector, exploring how India can leverage its technological prowess to drive global healthcare solutions. Discussions will delve into AI-driven healthcare advancements, data interoperability, and the disruptive potential of emerging technologies in shaping the future of life sciences.
Telangana: A Global Hub for Healthcare and Biotechnology
Telangana has cemented its reputation as a global leader in medical research, biotechnology, and pharmaceutical innovation. BioAsia has played a crucial role in strengthening the state’s position by fostering industry collaborations, encouraging investments, and showcasing breakthrough research in healthcare and life sciences.
Expressing his enthusiasm, Mr. Sridhar Babu, Minister for Industries and Commerce, Government of Telangana, stated: “BioAsia 2025 marks the 22nd edition of Asia’s leading life sciences and healthcare forum, bringing together global leaders to discuss AI-driven healthcare transformation, innovations in life sciences, data interoperability, and India’s potential in clinical trials. This year’s program is incredibly robust, with an outstanding speaker lineup that will make this the most impactful BioAsia event yet.”
Strategic Industry Partnerships and Startup Participation
A key feature of BioAsia 2025 is its collaborative approach, with leading consulting firms such as Deloitte, BCG, EY-Parthenon, and HealthArk playing a significant role in curating the agenda alongside industry partners and sponsors. Their involvement will ensure that the discussions remain relevant, insightful, and action-oriented, addressing pressing challenges and future trends in the life sciences sector.
Mr. Jayesh Ranjan, IAS, Special Chief Secretary, Industries & Commerce and Information Technology, Government of Telangana, highlighted the growing enthusiasm surrounding the event: “The diverse lineup of speakers at BioAsia 2025 further establishes it as a premier platform for knowledge exchange. I am particularly pleased to see strong participation from startups, which signals the growing dynamism in India’s life sciences ecosystem.”
The event will also emphasize the convergence of life sciences and emerging technologies, with a special focus on AI, personalized medicine, and clinical research. Mr. Shakthi Nagappan, CEO of BioAsia and Director of Telangana Life Sciences, emphasized this, stating: “India has immense potential to lead the convergence of life sciences and technology. With participation from global leaders like the CEO of Amgen and CIO of MSD, BioAsia 2025 will serve as a landmark platform for innovation. We are especially excited to welcome thought leaders like Dr. S. Somanath, whose expertise in space sciences and engineering will bring a unique perspective to tackling healthcare challenges.”
A Platform for Transformative Discussions and Global Collaborations
BioAsia 2025 is expected to serve as a key forum for engaging thought leaders, policymakers, and industry pioneers in high-impact discussions. The event will feature panel discussions, networking opportunities, and deep-dive sessions exploring AI-driven healthcare, cutting-edge advancements in clinical research, and personalized medicine.
With India emerging as a significant player in global healthcare and biotechnology, BioAsia 2025 will offer an unparalleled opportunity for collaboration, investment, and knowledge-sharing. As the event continues to grow in stature, it reinforces Hyderabad’s role as a global hub for life sciences innovation, further solidifying its contribution to the worldwide healthcare ecosystem.
